Clinical Trials Directory

Trials / Completed

CompletedNCT02938481

International Prospective Observational Cohort Study for Optimal Bowel Resection Extent and Central Radicality for Colon Cancer

Status
Completed
Phase
Study type
Observational
Enrollment
3,647 (actual)
Sponsor
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The T-REX study aims to clarify the actual status of metastatic lymph node (LN) distribution in colon cancer and provide reliable evidence regarding the optimal length of bowel resection and the extent of central lymph node dissection in colon cancer surgery.

Detailed description

In colon canser, the incidence of metastasis in the pericolic lymph nodes (LNs) located along the bowel and marginal artery is high. The optimal extent of bowel resection is closely associated with how we define 'regional' pericolic LNs, which should be resected because of the risk of metastasis. However, there are no standardised criteria for 'regional' LNs in the pericolic area. To establish a consensus for the extent of bowel resection and appropriate central LN dissection, international prospective stdies focusing on the distribution of metastatic LNs along the bowel and the primary feeding artery are conducted.

Conditions

Timeline

Start date
2013-05-30
Primary completion
2023-12-31
Completion
2025-01-31
First posted
2016-10-19
Last updated
2026-01-29

Locations

36 sites across 7 countries: Germany, Japan, Lithuania, Russia, South Korea, Taiwan, United Kingdom

Source: ClinicalTrials.gov record NCT02938481. Inclusion in this directory is not an endorsement.